ESR1 and breast carcinoma: Having shown that combining SM6Met with 4-OH-Tam not only resulted in a greater reduction of E2-induced ER+ breast cancer cell proliferation (Figure 1), but also that SM6Met synergistically enhanced the potency of 4-OH-Tam to reduce ER+ breast cancer cell proliferation (Figure 2), the mechanism whereby this occurred was of interest.